Nomura Holdings’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Nomura Holdings’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-214	Closed	-$9K	–	2732
2013 Q2	$9K	Buy	+214	New	+$7.99K	﹤0.01%	2177

Other funds holding ANTH

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Nomura Holdings's ANTH Position: Q3 2013 in Review

Nomura Holdings sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2013, closing a stake of 214 shares — an estimated $9K sold.

Nomura Holdings first reported a position in ANTH in Q2 2013 and held it in 1 quarter. The position peaked at $9K in Q2 2013. 32 funds tracked by Wall St. Rank hold ANTH as of Q3 2013.

Nomura Holdings reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2013 after selling out during the quarter.
Nomura Holdings sold 214 Anthera Pharmaceuticals, Inc. shares in Q3 2013, an estimated $9K.
Nomura Holdings first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 1 quarter.
Nomura Holdings's Anthera Pharmaceuticals, Inc. position peaked at $9K in Q2 2013.
32 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2013.

Based on Nomura Holdings's 13F filing for Q3 2013, filed 14 Nov 2013.